ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 73 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $710,000 | +10.8% | 147,996 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $641,000 | -5.0% | 147,996 | -9.7% | 0.00% | -33.3% |
| Q3 2020 | $675,000 | +52.7% | 163,830 | -5.1% | 0.00% | +50.0% |
| Q2 2020 | $442,000 | -11.4% | 172,630 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $499,000 | -23.7% | 172,630 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $654,000 | -25.9% | 172,630 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $883,000 | -17.5% | 172,630 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $1,070,000 | -12.8% | 172,630 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $1,227,000 | -16.8% | 172,630 | 0.0% | 0.01% | -33.3% |
| Q4 2018 | $1,474,000 | -57.3% | 172,630 | 0.0% | 0.01% | -47.8% |
| Q3 2018 | $3,456,000 | -22.5% | 172,630 | 0.0% | 0.02% | -32.4% |
| Q2 2018 | $4,459,000 | +8.1% | 172,630 | 0.0% | 0.03% | -2.9% |
| Q1 2018 | $4,126,000 | -29.5% | 172,630 | 0.0% | 0.04% | -31.4% |
| Q4 2017 | $5,850,000 | +60.1% | 172,630 | 0.0% | 0.05% | +70.0% |
| Q3 2017 | $3,655,000 | +21.1% | 172,630 | 0.0% | 0.03% | +15.4% |
| Q2 2017 | $3,019,000 | -0.1% | 172,630 | 0.0% | 0.03% | +4.0% |
| Q1 2017 | $3,021,000 | +3.6% | 172,630 | 0.0% | 0.02% | -13.8% |
| Q4 2016 | $2,917,000 | +3.0% | 172,630 | 0.0% | 0.03% | +11.5% |
| Q3 2016 | $2,833,000 | +8.4% | 172,630 | 0.0% | 0.03% | -3.7% |
| Q2 2016 | $2,614,000 | +4.7% | 172,630 | 0.0% | 0.03% | +3.8% |
| Q1 2016 | $2,496,000 | – | 172,630 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|